Literature DB >> 33607151

Identification of MCM family as potential therapeutic and prognostic targets for hepatocellular carcinoma based on bioinformatics and experiments.

Yu Lei1, Shuhui Wang1, Jingmei Liu1, Wei Yan1, Ping Han2, Dean Tian3.   

Abstract

AIMS: The minichromosome maintenance (MCM) complex is highly conserved, which has drawn increasing attention on physiology and pathology process. However, the role of MCM in hepatocellular carcinoma (HCC) remains largely unclear. We aimed to conduct systematic analysis of expression patterns, prognostic values and potential functions of nine MCM genes in HCC, thus identifying their role in HCC. MAIN
METHODS: In our study, we systemically analyzed the role of MCM in prognosis and HCC progression by several bioinformatics analysis tools. Immunohistochemical (IHC) assays were utilized to valid the protein expression of MCM in HCC and in vitro experiments were used to confirm the functions of MCMs in HCC proliferation. KEY
FINDINGS: Overexpression of MCM2-8 and MCM10 were found to be significantly associated with clinical parameters and poor prognosis of HCC patients. The function of MCM was mainly enriched in DNA replication. Moreover, MCM were also associated with several cancer pathway and drug sensitivity in HCC. Close correlations were observed between immune cell infiltration and MCM in HCC. Cell Counting Kit-8 (CCK-8) and clone formation assays suggested the role of MCM2-8 and MCM10 in HCC proliferation. SIGNIFICANCE: These results have implied that deregulated MCM played an important role in HCC progression and might be considered as potential therapeutic and prognostic targets for HCC.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bioinformatics; Cell proliferation; Hepatocellular carcinoma (HCC); Minichromosome maintenance (MCM); Prognosis

Mesh:

Substances:

Year:  2021        PMID: 33607151     DOI: 10.1016/j.lfs.2021.119227

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  A Novel Prognostic Signature Associated With the Tumor Microenvironment in Kidney Renal Clear Cell Carcinoma.

Authors:  Dongchen Pei; Chaojie Xu; Dong Wang; Xiaoxue Shi; Yurui Zhang; Yi Liu; Jianhua Guo; Nan Liu; Haipeng Zhu
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

2.  MCM6 Promotes Hepatocellular Carcinoma Progression via the Notch Pathway: Clinical, Functional, and Genomic Insights.

Authors:  Liangjuan Hou; Xin Zeng; Xuan Li; Chune Zhao; Juan Zou; Yukun Li; Gang Liu
Journal:  Comput Math Methods Med       Date:  2022-06-09       Impact factor: 2.809

3.  Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma.

Authors:  Hongjun Yu; Chaoqun Wang; Shanjia Ke; Miaoyu Bai; Yanan Xu; Shounan Lu; Zhigang Feng; Baolin Qian; Yue Xu; Menghua Zhou; Zihao Li; Bing Yin; Xinglong Li; Yongliang Hua; Yongzhi Zhou; Shangha Pan; Yao Fu; Yong Ma
Journal:  Front Immunol       Date:  2022-06-22       Impact factor: 8.786

4.  Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients.

Authors:  Zengwei Tang; Yuan Yang; Wen Chen; Enliang Li; Tingbo Liang
Journal:  J Transl Med       Date:  2022-01-29       Impact factor: 5.531

Review 5.  OB-Folds and Genome Maintenance: Targeting Protein-DNA Interactions for Cancer Therapy.

Authors:  Sui Par; Sofia Vaides; Pamela S VanderVere-Carozza; Katherine S Pawelczak; Jason Stewart; John J Turchi
Journal:  Cancers (Basel)       Date:  2021-07-03       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.